Industry Updates

Daiichi Sankyo Co Limited announced that it has entered into an agreement with Servier Canada whereby Servier Canada will market the oral, once-daily anti-coagulant edoxaban...

Takeda Pharmaceutical Company Limited announced revisions on an existing collaboration agreement, under which Takeda had rights to develop and commercialize multiple molecules / products from...

St. Jude Medical Expands Its Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies. ...

Gilead Sciences, Inc announced that the EC hs granted marketing authorization for the once-daily single tablet regimen (STR) Odefsey®(emtricitabine 200 mg/rilpivirine 25 mg/tenofovir alafenamide 25...

Allergan plc a leading global pharmaceutical company, announced the U.S. FDA has approved the company's supplemental New Drug Application (sNDA) to update the label for...

3rd Manufacturing Processes for Medical Technology Exhibition and Conference sets the stage as the industry’s knowledge-information exchange platform Established as Asia’s leading exhibition for the medical...

Apollo Hospitals Group, India’s foremost integrated healthcare conglomerate and Hainan Ecological Smart City Group (HESCG), a Chinese industrial park development & operations company from the...